weigh in Medical Technology

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

...iscontinue administration and institute appropriate treatment. Thrombotic events have been reported in patients receiving RiaSTAP. Physicians should weigh the benefits of administration versus the risks of thrombosis. RiaSTAP is made from pooled human plasma. Products made from human plasma may c...

Lenetix Launches Screening Study of New Down Syndrome Test

...s of millions of women and their unborn children," said Lenetix president and CEO Leonard H. Kellner. "Patients and doctors are constantly required to weigh the importance of an invasive and possibly unneeded procedure against the possible harm it could cause, and we are confident that this current IRB ass...

Behavioral Modification Programs Help Obese Children Manage Their Weight

...ound that after completing weight management programs, obese children would weigh between 3 pounds and 23 pounds less, on average, than obese children not in...obese 12-year-olds in a medium- to high-intensity health care program would weigh 17 to 18 pounds less than their obese peers. In contrast, children enrolled...

New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI

...rmal physiologic range, which may alleviate symptoms related to low testosterone. As with any medication, patients should work with their physician to weigh treatment benefits and risks. About AndroGel(R) AndroGel, the first U.S. Food and Drug Administration (FDA)-approved testosterone gel available in...

White Nose Syndrome: Is Pennsylvania Next?

...itored intensively this fall and next winter to develop baseline data in the event WNS shows up in Pennsylvania." Turner said. "Mostly, we'll band and weigh bats taken in traps at entrances, and then see if they return. Recording weights will help us ascertain whether bats are entering hibernacula ill-prep...

U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older

...t of hypersensitivity reactions should be available for immediate use in the event of a reaction. For pediatric and adolescent patients with JIA who weigh less than 75 kg, ORENCIA(R) (abatacept) should be administered as a 30-minute intravenous infusion at a dose of 10 mg/kg specifically calculated based...

Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns

...' data indicates black infants are less prone to develop significant hyperbilirubinemia. "More research on risk-assessment strategies is needed to weigh the cost of implementing a universal program and its effectiveness for preventing severe hyperbilirubinemia against false test results, unnecessary te...

Survey Finds At-Risk Consumers Interested in OTC Statin

...e being made public on the eve of a joint meeting of two Food and Drug Administration Advisory Committees. At that meeting, members of the public will weigh in on the possibility of making the current Rx cholesterol-lowering statin MEVACOR (lovastatin) available as an OTC drug. The survey was commissioned ...

Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos

... is removed from an embryo on the third day of embryonic development. The 3 billion base-pairs of nucleic acid that make up a single copy of human DNA weigh only 6 trillionths of a gram, which is too small to allow analysis. It is necessary first to copy this code over one million times with great fidelity...

Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator

...tly - and are key to the support of adaptive trials. Monte Carlo statistical techniques allow the application to simulate a multiplicity of scenarios, weigh the possibilities, and deliver answers with high - and specific - degrees of confidence. "I'm proud that our team was able to pack so many significan...

Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting

...ome other drugs in this class. Physicians considering concomitant treatment with these or other agents associated with myopathy should weigh carefully the potential benefits and risks and should monitor and advise patients to report any signs or symptoms of unexplained muscle ...

Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target

...007. A second trial, the ENSURE trial, is an efficacy and safety trial with corifollitropin alfa 100 µg designed specifically for women who weigh less than 60 kg (133 lbs). This double-blind study comparing corifollitropin alfa with Puregon® was started in January 2007 in 19 clinical trial c...